Exosome isolation & detection kits
AMSBIO have introduced a new range of proprietary reagents designed for researchers investigating targeted cancer therapy.
AMSBIO have introduced a new range of proprietary reagents designed for researchers investigating targeted cancer therapy.
99 problems? Cell culture doesn’t have to be one of them
A sneak-peek into the busiest microbiome laboratory: what technologies assist large projects and what happens to all the data from thousands of samples
In this popular on-demand webinar, learn more about novel assays being used to identify new CD47 and phagocyte modulators
Join tomorrow's expert webinar on how to improve the robustness of your live-cell assays
Cobas 6800/8800 system can be used to test for EBV and BKV in transplant patients
Join this expert webinar to learn how to increase throughput in sample prep and qPCR
From assay inception to dose response and medicinal chemistry, discover the cutting-edge technology used to identify small molecules with clinical potential, in this SelectScience interview
R&D collaboration to develop NGS-based predictive antibiotic resistance testing powered by ARESdb
Cloud-based solution automates NGS data analysis for liquid biopsy and FFPE workflows
Tell us which new products made the most difference to your lab work and you’ll have the chance to win one of four $500 Amazon gift cards
New data show NfL may be a biomarker for predicting future disability outcomes
Delivers enhanced galactosylation for improved protein quality, and antibody binding and function
Meet one of the first cryo-EM groups set on delivering a resolution revolution
Flexible, modular system, designed for 21CFR Part 11 compliance
First in a new range to advance identification and selection of cells with the highest productivity
New facilities expand services offering to Irish and international customers
Approval puts company on track to offering a complete spectral flow cytometry solution to the Chinese market
In this expert webinar presented by Dr. Stefan Hosenöder, find out how to improve the robustness of your live-cell assays
Study aims to develop a rapid point-of-care diagnostic based on multiple biomarkers to detect emergent sepsis